Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6ACX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $72,881
Award facts
- Contract value 100% obligated
- $72,880.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $72,880.74 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The award was issued under a firm fixed-price contract with no set-aside designation and is set for ultimate completion by August 12, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide. Jakafi (ruxolitinib) is a prescription medication used in the treatment of myelofibrosis and other myeloproliferative disorders, reflecting the vendor's established portfolio of oncology and specialty pharmaceutical products supplied to Department of Defense healthcare systems. The company's consistent success in securing federal pharmaceutical contracts demonstrates its critical role as a supplier within the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6ACX?
SPE2DX25F6ACX was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2DX25F6ACX worth?
The government has obligated $72,881 on SPE2DX25F6ACX.
Is contract SPE2DX25F6ACX an order under another contract?
Yes. SPE2DX25F6ACX is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ACX competed?
The extent of competition for SPE2DX25F6ACX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award